Tentarix Biotherapeutics

Conditionally Active Biologics

San Diego, United States · Founded 2020 · $85.0M raised

Headquarters
San Diego
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$85.0M
Last Round
$35.0M Series BSep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Creates innovative protein therapeutics leveraging synthetic biology

Summary

Tentarix Biotherapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $85.0M in total across 2 rounds, most recently a $35.0M Series B round in Sep 2023.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2023
$35.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tentarix Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tentarix-biotherapeutics"><img src="https://indexed.vc/api/badge/company/tentarix-biotherapeutics" alt="Tentarix Biotherapeutics on Indexed.vc" width="260" height="76" /></a>